Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Dabigza 110 Capsule

Prescription Icon
Prescription Required

Marketer

Glenmark Pharmaceuticals Ltd

Salt Composition

Dabigatran Etexilate (110mg)

Overview Dabigza 110 Capsule

Edoxaban 110mg capsules act as a blood thinner, preventing and treating blood clots. This medication lowers stroke and heart attack risk by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clots, it also benefits those post-knee or hip replacement surgery. It can be taken with or without food, but consistent daily timing is recommended. Long-term, even lifelong, use may be necessary; discontinuation or dosage changes require physician approval to avoid increased risk of stroke, heart attack, or thrombosis. Lifestyle modifications like quitting smoking, healthy eating, exercise, and weight management further reduce clotting risk. Common side effects include gastrointestinal upset and increased bleeding (nosebleeds, bruising). Report any side effects immediately. Other potential side effects include headaches, seizures, allergic reactions, visual changes, and fatigue. Contraindicated in individuals with severe kidney or liver disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring is unnecessary.

Uses of Dabigza 110 Capsule

Preventing and managing blood clots

Major Benefits of Dabigza 110 Capsule:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Dabigza 110 Capsules can be ingested with or without food; however, consistent daily timing is recommended.

Common Side effects of Dabigza 110 Capsule:

  • Nausea
  • Anemia (low number of red blood cells)
  • Gastrointestinal bleeding
  • Dyspepsia
  • Diarrhea
  • Abdominal pain
  • Nosebleeds
  • Skin bleeding

How to use Dabigza 110 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Dabigza 110 Capsules. These capsules can be taken with or without food, although consistent timing is recommended.

How Dabigza 110 Capsule works:

Boehringer Ingelheim's Dabigatran etexilate 110 mg capsule is a new type of blood thinner. Its mechanism of action involves inhibiting clot development within the circulatory system.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dabigza 110 Capsule with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dabigatran 110mg capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Dabigatran 110 mg capsules is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Dabigza 110 Capsules.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Dabigza 110 mg capsules; dosage modification may be necessary. A physician's consultation is advised. Dabigza 110 mg capsules are generally unsuitable for individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Dabigatran 110 mg capsules cautiously. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Dabigza 110 Capsule :

Should you forget a Dabigza 110 Capsule dose, ingest it promptly that same day. However, omit the missed dose if it's impossible to administer it at least six hours prior to your next planned dose. Never compensate for a missed dose by taking a double dose.

Facts to Know About Dabigza 110 Capsule

LabelValue
Chemical Category Benzimidazole-based compound
Developing Habits No.
Treatment Category Heart
Action class Oral direct thrombin inhibitor

FAQs on Dabigza 110 Capsule

Dabigatran 110 mg capsules are typically prescribed twice daily, approximately 12 hours apart, at consistent times.
Dabigatran (Dabigza 110 Capsule) and alcohol can interact, increasing bleeding risk. Alcohol also raises your chances of a gastric ulcer, which can further increase bleeding. Therefore, avoid alcohol while taking this medication. Report any bleeding to your doctor immediately.
Unlike many other anticoagulants, Dabigatran (Dabigza 110 Capsule) is not typically linked to hair loss. While rare cases have been reported, consult your physician if you experience hair loss while using this medication to determine the cause.
Dabigza 110 Capsules lower your risk of blood clots in your legs, lungs, heart, and brain. While you may not notice any immediate effects, continue taking this medication as directed by your doctor to receive its full benefits.
Dabigza 110 Capsules typically do not impair liver function, unlike other anticoagulants. While prolonged use might slightly increase the risk of liver injury in individuals with pre-existing elevated liver enzymes, this risk remains lower than with alternative anticoagulants. Prior liver disease should be disclosed to your physician before commencing treatment.
Store Dabigatran Etexilate 110 mg Capsules at room temperature (15°C to 30°C or 59°F to 86°F) in a dry place, protecting them from moisture. Keep the bottle tightly closed and out of children's reach. Discard any unused capsules four months after opening the bottle.
Dabigatran (Dabigza 110 Capsule) raises your risk of bleeding. Avoid activities that could cause injury. Report any unusual bleeding or bruising to your doctor promptly.
Do not take Dabigza 110 Capsule if you have unusual bleeding, are allergic to it, or have artificial heart valves. Inform your doctor about any history of, or plans for, heart valve replacement.
Dabigza 110 Capsule
396
MRP 459
13% off